Price T Rowe Associates Inc Edwards Lifesciences Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,541,783 shares of EW stock, worth $263 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,541,783
Previous 7,335,738 51.72%
Holding current value
$263 Million
Previous $678 Million 65.51%
% of portfolio
0.03%
Previous 0.08%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$59.7 - $93.78 $226 Million - $356 Million
-3,793,955 Reduced 51.72%
3,541,783 $234 Million
Q2 2024

Aug 14, 2024
BUY
$84.3 - $94.31 $69.1 Million - $77.3 Million
819,478 Added 12.58%
7,335,738 $678 Million
Q1 2024

May 15, 2024
BUY
$72.54 - $95.56 $173 Million - $228 Million
2,390,137 Added 57.93%
6,516,260 $623 Million
Q4 2023

Feb 14, 2024
BUY
$61.71 - $77.76 $52 Million - $65.5 Million
842,848 Added 25.67%
4,126,123 $315 Million
Q3 2023

Nov 14, 2023
BUY
$69.28 - $93.38 $171 Million - $231 Million
2,469,870 Added 303.65%
3,283,275 $227 Million
Q2 2023

Aug 14, 2023
SELL
$81.41 - $94.33 $1.47 Million - $1.71 Million
-18,108 Reduced 2.18%
813,405 $76.7 Million
Q1 2023

May 15, 2023
BUY
$74.26 - $84.51 $1.57 Million - $1.78 Million
21,079 Added 2.6%
831,513 $68.8 Million
Q4 2022

Feb 14, 2023
BUY
$68.3 - $87.44 $271,014 - $346,961
3,968 Added 0.49%
810,434 $60.5 Million
Q3 2022

Nov 14, 2022
SELL
$82.37 - $107.29 $36,901 - $48,065
-448 Reduced 0.06%
806,466 $66.6 Million
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $7.24 Million - $10.7 Million
-83,655 Reduced 9.39%
806,914 $76.7 Million
Q1 2022

May 16, 2022
SELL
$101.96 - $128.34 $5.52 Million - $6.95 Million
-54,134 Reduced 5.73%
890,569 $105 Million
Q4 2021

Feb 14, 2022
SELL
$106.37 - $130.68 $3.24 Million - $3.98 Million
-30,418 Reduced 3.12%
944,703 $122 Million
Q3 2021

Nov 15, 2021
SELL
$102.91 - $122.75 $1.6 Million - $1.9 Million
-15,517 Reduced 1.57%
975,121 $110 Million
Q2 2021

Aug 16, 2021
SELL
$83.84 - $104.76 $901,866 - $1.13 Million
-10,757 Reduced 1.07%
990,638 $103 Million
Q1 2021

May 17, 2021
SELL
$78.68 - $90.67 $6.16 Million - $7.1 Million
-78,254 Reduced 7.25%
1,001,395 $83.8 Million
Q4 2020

Feb 16, 2021
BUY
$71.69 - $91.23 $77.4 Million - $98.5 Million
1,079,649 New
1,079,649 $98.5 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
457M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email